These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8625762)

  • 1. Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat.
    Stadnicki A; DeLa Cadena RA; Sartor RB; Bender D; Kettner CA; Rath HC; Adam A; Colman RW
    Dig Dis Sci; 1996 May; 41(5):912-20. PubMed ID: 8625762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
    Stadnicki A; Sartor RB; Janardham R; Majluf-Cruz A; Kettner CA; Adam AA; Colman RW
    FASEB J; 1998 Mar; 12(3):325-33. PubMed ID: 9506476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat.
    Dela Cadena RA; Stadnicki A; Uknis AB; Sartor RB; Kettner CA; Adam A; Colman RW
    FASEB J; 1995 Mar; 9(5):446-52. PubMed ID: 7896018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.
    Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB
    Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications].
    Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW
    Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation.
    DeLa Cadena RA; Laskin KJ; Pixley RA; Sartor RB; Schwab JH; Back N; Bedi GS; Fisher RS; Colman RW
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G213-9. PubMed ID: 1996642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contact system in experimental enterocolitis.
    Stadnicki A; DeLa Cadena RA; Sartor RB; Kettner CA; Colman RW
    Immunopharmacology; 1996 Jun; 33(1-3):314-6. PubMed ID: 8856173
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma and tissue kallikrein in arthritis and inflammatory bowel disease.
    Colman RW
    Immunopharmacology; 1999 Sep; 43(2-3):103-8. PubMed ID: 10596840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats.
    Stadnicki A; Chao J; Stadnicka I; Van Tol E; Lin KF; Li F; Sartor RB; Colman RW
    Am J Physiol; 1998 Oct; 275(4):G854-61. PubMed ID: 9756518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat.
    Uknis AB; DeLa Cadena RA; Janardham R; Sartor RB; Whalley ET; Colman RW
    Inflamm Res; 2001 Mar; 50(3):149-55. PubMed ID: 11339503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
    Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
    Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis.
    Sartor RB; DeLa Cadena RA; Green KD; Stadnicki A; Davis SW; Schwab JH; Adam AA; Raymond P; Colman RW
    Gastroenterology; 1996 May; 110(5):1467-81. PubMed ID: 8613052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats.
    Isordia-Salas I; Pixley RA; Li F; Sainz I; Sartor RB; Adam A; Colman RW
    Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G180-6. PubMed ID: 12065305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation.
    Theiss AL; Fuller CR; Simmons JG; Liu B; Sartor RB; Lund PK
    Gastroenterology; 2005 Jul; 129(1):204-19. PubMed ID: 16012948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.
    Espinola RG; Uknis A; Sainz IM; Isordia-Salas I; Pixley R; DeLa Cadena R; Long W; Agelan A; Gaughan J; Adam A; Colman RW
    Am J Pathol; 2004 Sep; 165(3):969-76. PubMed ID: 15331420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic intestinal inflammation and angiogenesis in genetically susceptible rats is modulated by kininogen deficiency.
    Isordia-Salas I; Pixley RA; Li F; Sainz I; Balfour Sartor R; Adam A; Colman RW
    Int Immunopharmacol; 2002 Dec; 2(13-14):1895-905. PubMed ID: 12489803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
    Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
    Arch Med Res; 2004; 35(5):369-77. PubMed ID: 15610905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat.
    Blais C; Couture R; Drapeau G; Colman RW; Adam A
    Arthritis Rheum; 1997 Jul; 40(7):1327-33. PubMed ID: 9214434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
    Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
    Arch Med Res; 2005; 36(1):87-95. PubMed ID: 15900628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.